Investigating Musculoskeletal Health and Wellbeing Newsletter
December 13, 2021
Accelerated TMS for Pain Inhibition: The BoostCPM Study
November 11, 2021
What’s this & why would it help with pain? There is more and more evidence that effective treatments need to focus on any disturbed communication between brain areas that are fundamental to the perception of pain. Logically, if abnormal brain connectivity patterns are reversed, this should help to alleviate chronic pain. Transcranial Magnetic Stimulation (TMS) …
The East Midlands Knee Pain Multiple Randomised Controlled Trial Cohort Study
May 20, 2021
Acceptability of a nurse-led non-pharmacological complex intervention for knee pain: Nurse and patient views and experiences The research team led by Professor Abhishek developed and tested the feasibility of a complex intervention for knee pain delivered by a nurse, and comprising both non-pharmacological and pharmacological interventions. In the first phase, the acceptability of the non-pharmacological …
Persistent knee pain following total knee replacement
The problem of knee Osteoarthritis (OA), and therefore chronic pain and disability, is on the rise. Although total knee replacement (TKR) has significantly improved pain and functioning for most end-stage knee OA patients, unfortunately 20% of patients still report persistent knee pain following TKR. Third year medical student, Lauren Quinn, undertook a project which aimed …
Identifying key elements of non-pharmacological treatment package for fibromyalgia: Evidence synthesis and Delphi exercise
April 14, 2020
Fibromyalgia (FM) is a long-term condition that causes pain all over the body and currently has no cure. However, there are treatments which can help relieve some of the symptoms and make the condition easier to live with. Burak Kundakci, a PhD student at the University of Nottingham, conducted research into a package of care …
Investigating the adverse effects related with long term use of paracetamol
April 3, 2020
Guidelines often recommend paracetamol as a first-line analgesic, particularly for osteoarthritis (OA), based on its perceived safety. However, there is growing discussion, highlighted in the National Institute for Health and Care Excellence OA (NICE) 2014 guidance on OA, that paracetamol is not as safe as originally thought, especially at the highest therapeutic dose of 4gm/day. …